Focal enhancement of expression of c-Met/hepatocyte growth factor receptor in the myocardium in human myocardial infarction

被引:22
作者
Sato, T
Tani, Y
Murao, S
Fujieda, H
Sato, H
Matsumoto, M
Takeuchi, T
Ohtsuki, Y
机构
[1] Royal Prince Alfred Hosp, Dept Cardiol, Cath Lab, Camperdown, NSW 2050, Australia
[2] Matsuyama City Hosp, Dept Cardiovasc Med, Matsuyama, Ehime 7900067, Japan
[3] Kochi Med Sch, Dept Pathol, Kochi 7838505, Japan
关键词
c-Met; hepatocyte growth factor; myocardial infarction; autopsy;
D O I
10.1016/S1054-8807(01)00079-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To determine the distribution and expression level of hepatocyte growth factor (HGF) specific receptor. c-Met, in human myocardial infarction. Autopsies of 13 patients who died without heart diseases (control) and 13 patients with a history of myocardial infarction (2 h to 10 years before death). The harvested myocardial tissues were stained with hematoxylin-eosin (H&E) and immunohistochemically stained for c-Met expression by the avidin-biotin-horseradish peroxidase complex method using an antibody to c-Met. C-Met expression was only slightly increased in control subjects and in noninfarcted myocardium of the test group. In contrast, high expression was noted in the peripheral region of the myocardial infarction and in some hypertrophic myocardial cells. C-Met was not expressed in the infarcted myocardium, but overexpression was noted in the surrounding myocardial cells of blood vessels and in the subendocardium and subepicardium in a band-like pattern. The expression level of c-Met was most enhanced at the time of appearance of coagulative necrosis and least in the myocardium of subjects with old infarcts. Our results indicate that HGF preferentially reaches the ischemic regions of the myocardium and has local and direct effects on the myocardium in patients with myocardial infarction. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:235 / 240
页数:6
相关论文
共 26 条
[1]   APOPTOSIS OF VASCULAR ENDOTHELIAL-CELLS BY FIBROBLAST GROWTH-FACTOR DEPRIVATION [J].
ARAKI, S ;
SHIMADA, Y ;
KAJI, K ;
HAYASHI, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 168 (03) :1194-1200
[2]   Elevated levels of interleukin-6 in unstable angina [J].
Biasucci, LM ;
Vitelli, A ;
Liuzzo, G ;
Altamura, S ;
Caligiuri, G ;
Monaco, C ;
Rebuzzi, AG ;
Ciliberto, G ;
Maseri, A .
CIRCULATION, 1996, 94 (05) :874-877
[3]   IDENTIFICATION OF THE HEPATOCYTE GROWTH-FACTOR RECEPTOR AS THE C-MET PROTOONCOGENE PRODUCT [J].
BOTTARO, DP ;
RUBIN, JS ;
FALETTO, DL ;
CHAN, AML ;
KMIECIK, TE ;
VANDEWOUDE, GF ;
AARONSON, SA .
SCIENCE, 1991, 251 (4995) :802-804
[4]   3 ADDITIONAL DNA POLYMORPHISMS IN THE MET GENE AND D7S8 LOCUS - USE IN PRENATAL-DIAGNOSIS OF CYSTIC-FIBROSIS [J].
DEAN, M ;
OCONNELL, P ;
LEPPERT, M ;
PARK, M ;
AMOS, JA ;
PHILLIPS, DG ;
WHITE, R ;
WOUDE, GFV .
JOURNAL OF PEDIATRICS, 1987, 111 (04) :490-495
[5]   Autocrine paracrine effects of overexpression of hepatocyte growth factor gene on growth of endothelial cells [J].
Hayashi, S ;
Morishita, R ;
Higaki, J ;
Aoki, M ;
Moriguchi, A ;
Kida, I ;
Yoshiki, S ;
Matsumoto, K ;
Nakamura, T ;
Kaneda, Y ;
Ogihara, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 220 (03) :539-545
[6]  
Hayashi S, 1999, CIRCULATION, V100, P301
[7]   ANGIOGENESIS IN SKELETAL AND CARDIAC-MUSCLE [J].
HUDLICKA, O ;
BROWN, M ;
EGGINTON, S .
PHYSIOLOGICAL REVIEWS, 1992, 72 (02) :369-417
[8]   Immediate increase in circulating hepatocyte growth factor/scatter factor by heparin [J].
Matsumori, A ;
Ono, K ;
Okada, M ;
Miyamoto, T ;
Sato, Y ;
Sasayama, S .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1998, 30 (10) :2145-2149
[9]   Increased circulating hepatocyte growth factor in the early stage of acute myocardial infarction [J].
Matsumori, A ;
Furukawa, Y ;
Hashimoto, T ;
Ono, K ;
Shioi, T ;
Okada, M ;
Iwasaki, A ;
Nishio, R ;
Sasayama, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 221 (02) :391-395
[10]   Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy [J].
Morishita, R ;
Nakamura, S ;
Hayashi, S ;
Taniyama, Y ;
Moriguchi, A ;
Nagano, T ;
Taiji, M ;
Noguchi, H ;
Takeshita, S ;
Matsumoto, K ;
Nakamura, T ;
Higaki, J ;
Ogihara, T .
HYPERTENSION, 1999, 33 (06) :1379-1384